Join The Fight
Fighting prostate cancer is not a battle you have to take on alone. Get off the bench and join a team. Let's win this together!
Back to Resources
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Enzalutamide with or without Galunisertib in Treating Patients with Metastatic Castrate Resistant Prostate Cancer
Abiraterone Acetate, Prednisone, and Androgen Receptor Antagonist ARN-509 with or without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
Carbon-11 Acetate PET/CT Imaging in Evaluating Response to Radium Ra 223 Dichloride Therapy in Patients with Hormone-Resistant Metastatic Prostate Cancer